Phil Hormel

1.2k total citations
6 papers, 824 citations indexed

About

Phil Hormel is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Phil Hormel has authored 6 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 1 paper in Cardiology and Cardiovascular Medicine and 1 paper in Physiology. Recurrent topics in Phil Hormel's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Respiratory and Cough-Related Research (1 paper) and Occupational and environmental lung diseases (1 paper). Phil Hormel is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Respiratory and Cough-Related Research (1 paper) and Occupational and environmental lung diseases (1 paper). Phil Hormel collaborates with scholars based in Germany, United States and Italy. Phil Hormel's co-authors include Williamson Z. Bradford, Talmadge E. King, Carlo Albera, Paul W. Noble, Dominique Valeyre, Ulrich Costabel, Roland M. du Bois, W. Richard Webb, Steven A. Sahn and Kevin M. Brown and has published in prestigious journals such as The Lancet, Circulation and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Phil Hormel

6 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phil Hormel Germany	4	772	277	82	69	61	6	824
Eiyasu Tsuboi Japan	8	792 1.0×	245 0.9×	153 1.9×	117 1.7×	53 0.9×	36	894
Hirotsugu Hasegawa Japan	12	379 0.5×	168 0.6×	57 0.7×	26 0.4×	30 0.5×	35	501
Tetsujiro Fukami Japan	10	228 0.3×	143 0.5×	92 1.1×	87 1.3×	19 0.3×	14	351
Florence Jeny France	13	363 0.5×	341 1.2×	69 0.8×	22 0.3×	16 0.3×	44	480
Shigeki Kuroishi Japan	12	278 0.4×	136 0.5×	79 1.0×	23 0.3×	31 0.5×	24	449
Hirotaka Nishikiori Japan	13	311 0.4×	83 0.3×	50 0.6×	20 0.3×	25 0.4×	35	398
Hiroyuki Koba Japan	7	329 0.4×	64 0.2×	50 0.6×	28 0.4×	36 0.6×	20	389
R Mikami United States	3	360 0.5×	536 1.9×	96 1.2×	71 1.0×	26 0.4×	6	636
A. N. Walker Australia	4	288 0.4×	378 1.4×	66 0.8×	50 0.7×	13 0.2×	4	440
Isamu Cho Japan	9	138 0.2×	83 0.3×	156 1.9×	78 1.1×	30 0.5×	14	333

Countries citing papers authored by Phil Hormel

Since Specialization

Citations

This map shows the geographic impact of Phil Hormel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phil Hormel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phil Hormel more than expected).

Fields of papers citing papers by Phil Hormel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phil Hormel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phil Hormel. The network helps show where Phil Hormel may publish in the future.

Co-authorship network of co-authors of Phil Hormel

This figure shows the co-authorship network connecting the top 25 collaborators of Phil Hormel. A scholar is included among the top collaborators of Phil Hormel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phil Hormel. Phil Hormel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Costabel, Ulrich, Carlo Albera, Williamson Z. Bradford, et al.. (2014). Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone in patients with idiopathic pulmonary fibrosis.. PubMed. 31(3). 198–205. 42 indexed citations

2.

Costabel, Ulrich, Carlo Albera, Williamson Z. Bradford, et al.. (2012). Analysis of lung function and survival in RECAP: An open-label extension study of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF). 40. 2820–2820. 3 indexed citations

3.

King, Talmadge E., Carlo Albera, Williamson Z. Bradford, et al.. (2009). Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial. The Lancet. 374(9685). 222–228. 371 indexed citations

4.

Bois, Ron du, Carlo Albera, Williamson Z. Bradford, et al.. (2009). Predictors of Mortality in Patients with Idiopathic Pulmonary Fibrosis (IPF).. Document Server@UHasselt (UHasselt). A1114–A1114. 7 indexed citations

5.

Lynch, David A., J. David Godwin, Sharon Safrin, et al.. (2005). High-Resolution Computed Tomography in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 172(4). 488–493. 400 indexed citations

6.

Bakhai, Ameet, et al.. (2002). Cost-effectiveness of coronary stenting and abciximab for patients with AMI: Results from the CADILLAC trial. Circulation. 106(19). 518–518. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact